Guest Post: Prometheus v Mayo – A European view Patently-O The forward references of the '633 patent include US 7524851, whose equivalent EP-B-1695092 has a main claim that reads: wherein a concentration ratio greater than 0.85 is indicative of superior clinical responsiveness to azathioprine therapy, ... |
